ISSN: 2157-7013
+44 1300 500008
Commentary - (2022)
Hair follicle (HF) regeneration can be understood generally in two perspectives. One is de novo synthesis (neogenesis) of hair follicles and another is the promotion of hair follicle growth, which means facilitating the hair cycle transition from telogen (resting phase) to anagen (active phase). Recently, some notable studies applying Extracellular Vesicles (EVs) to both HF neogenesis and the promotion of HF growth have been reported implying the possibility to overcome the shortages of current hair loss therapies [1]. This paper, in two perspectives mentioned above, explores the attempts for the hair follicle regeneration.
De novo synthesis (neogenesis) of hair follicles
The strategy for neogenesis can be designed by considering the developmental process of HFs as a skin appendage. Initial hair induction relies on dermal-epidermal interactions which causes dermal placode formation, and subsequently differentiations into dermal papilla. Dermal Papilla (DP) then achieves the hairinductive potency (trichogenecity) to create a hair shaft by the active crosstalk with adjacent epidermal microenvironment. Therefore, in order to realize hair follicle neogenesis, acquisition of hair-inductive (trichogenic) DP cells is an overarching concern. Various approaches to address the concern have been tried such as supplementation of necessary factors (keratinocyte conditioned medium, or activators of Wnt/β-catenin) to DP cells and the application of three-Dimensional (3D) spheroid culture to DP cells [2]. Spheroid formation of human DP cells actually makes them more representative of the intact in vivo DPs regarding to trichogenicity [3,4]. In addition, necessary genes and molecular signallings of 3D cultured DP spheres (3D-DPs) involved in hair follicle neogenesis have been investigated for enhancing the trichogenicity of 3D-DPs or discovering any clues to find any alternatives to them [5-7].
Inspired by the significance of 3D-DPs, the effect of EVs derived from 3D-DPs (3D-DPs-EVs) on hair follicle neogenesis has been evaluated. When 3D-DPs-EVs were additionally treated to cultured 3D-DPs, the number of induced hair formation was increased by 2-folds compared to that of control 3D-DPs [8]. This study has brought up a topic about the autocrine effect mediated by EVs while DP cells were 3D cultured. Considering that DP cells are a type of adult mesenchymal stem cells, Seo, et al. evaluated human Adipose Derived Mesenchymal Stem Cells (ADSCs) as Three-Dimensional (3D) spheroid forms to replace the trichogenic 3D-DPs [9]. However, 3D-ADSCs were found not to be a promising option as trichogenic dermal components as they showed poor capability to induce human HF formation. A study has been very recently reported on the application of EVs derived from mouse ADSCs (mADSCs- EVs). Wu, et al. showed that mADSCs- EVs are capable to enhance mouse HF neogenesis by the induction of Platelet Derived Growth Factor (PDGF) and vascular endothelial growth factor (VEGF) [10].
The promotion of hair growth
Hu, et al. have recently revealed that the treatment of 3D-DPs is more effective to promote hair growth than 5% minoxidil (widely used as a positive control for hair growth) [11]. They have further elucidated that the growth promotion effect can be achieved by 3D-DPs-EVs only, instead of 3D-DPs, and the effect is attributed to micRNA-218-4p in the EVs acting as an activator of β-catenin signalling [11]. Dermal Fibroblasts (DFs) are one of dermal cell populations. Transfecting DFs with essential factors and treatment of growth factors to DFs have been tried to transfer their characteristics similar to DP cells. Riche, et al. found that EVs derived from the DFs stimulated hair growth and the stimulatory effect was more strengthened when DFs were pre-treated with both Basic Fibroblast Growth Factor (bFGF) and PDGF [12]. In accordance with another study on the use of Bone Marrow-Derived Mesenchymal Stem Cells (BM-MSC), EVs derived from BM-MSC have a potential to augment both DP cells’ activity and hair cycle progression from telogen to anagen [13].
It is reported that perifollicular macrophages promoted hair growth, thereafter which was through TNF-induced AKT/ β-catenin signalling in Lgr5+ HF stem cells [14,15]. Inspired by the active effect of macrophages on HF stem cell dynamics, Rajendran, et al. showed that EVs derived from macrophages (MAC-EVs) upregulated hair-inductive molecules in DP cells and facilitated hair growth, which has ever not been reported [16]. The canonical Wnt signalling activation results in the nuclear translocation of β-catenin and the transcription of downstream hair-inductive gene. A recent study showed that perifollicular macrophages activate DP cells through canonical Wnt ligands and prolong the anagen phase of human HF [17]. From the previous MAC-EVs study, we have put our focus on EVs, expecting them as novel secretory molecules for the crosstalk between macrophage and DP cells. We analysed the Wnt3a, Wnt7b expression of MAC-EVs compared to that of macrophage itself. Interestingly, Wnt3a and Wnt7b were even far enriched in MAC-EVs than macrophage, and more than 95% them were associated with the membrane of MAC-EVs. The Wnt3a and Wnt7b stimulated the receptors on DP cells (such as Frizzled and LRP5/6), which readily activated Wnt/β-catenin signalling pathway. This was also verified by the mRNA expression analysis of downstream target genes (Axin2, Lef1). With the treatment of 20μg MAC-EVs, Axin2 was 6-folds upregulated and Lef1 was 40-folds upregulated. Moreover, the MAC-EVs significantly enhanced the proliferation, migration, and levels of hair-inductive markers (such as alkaline phosphatase and versican) of DP cells. Additionally, MAC-EVs increased the levels of the survival protein Bcl-2 as well as phosphorylated AKT. DP cells treated with MAC-EVs elevated the expression of VEGF and keratinocyte growth factor (KGF), which is stimulatory paracrine factors for the proliferation of surrounding matrix cells and so, prompt hair shaft growth.
Studies on extracellular vesicles as novel therapeutic tools have been rapidly growing. Our findings underscore the feasibility of EVs which are easily isolated from macrophage immune cells and furthermore suggest a possibility of EVs as a topical medication. To reserve the clinical avenue of EVs, it is necessary to elucidate the effective components in them and scrutinize the novel biological mechanisms in a comprehensive manner together with Wnt/β- catenin signalling.
This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science & ICT(2017M3A9G405295).
Author has declared that he has no conflict of interest.
[Cross Ref] [Google Scholar] [PubMed]
[Cross Ref] [Google Scholar] [PubMed]
[Cross Ref] [Google Scholar] [PubMed]
[Cross Ref] [Google Scholar] [PubMed]
[Cross Ref] [Google Scholar] [PubMed]
[Cross Ref] [Google Scholar] [PubMed]
[Cross Ref] [Google Scholar] [PubMed]
[Cross Ref] [Google Scholar] [PubMed]
[Cross Ref] [Google Scholar] [PubMed]
[Cross Ref] [Google Scholar] [PubMed]
[Cross Ref] [Google Scholar] [PubMed]
[Cross Ref] [Google Scholar] [PubMed]
[Cross Ref] [Google Scholar] [PubMed]
[Cross Ref] [Google Scholar] [PubMed]
[Cross Ref] [Google Scholar] [PubMed]
[Cross Ref] [Google Scholar] [PubMed]
[Cross Ref] [Google Scholar] [PubMed]
Citation: Seo CH (2022) Strategies for the Hair Follicle Regeneration: Extracellular Vesicles as a Novel Therapeutic Biomolecule. J Cell Sci Therapy. S10:353.
Received: 14-Apr-2022, Manuscript No. JCEST-22-16845; Editor assigned: 18-Apr-2022, Pre QC No. JCEST-22-16845(PQ); Reviewed: 02-May-2022, QC No. JCEST-22-16845; Revised: 09-May-2022, Manuscript No. JCEST-22-16845(R); Published: 16-May-2022 , DOI: 10.35248/2157-7013.22.S10.353
Copyright: © 2022 Seo CH. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.